Abstract
In comparing cardiovascular death between patients receiving intensified antiplatelet therapy after percutaneous coronary intervention and controls given standard-dose clopidogrel, the meta-analysis by Aradi et al. [1] handled a very critical data set because only 10 randomised studies were available and more than half of the event frequencies were zero (13 out of 20).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
